Want to see USPH full AI Analyst Report?
USPH Stock Chart & Stats
$74.58
$1.61(2.21%)
At close: 4:00 PM EDT
$74.58
$1.61(2.21%)
Day’s Range― - ―
52-Week Range$58.19 - $93.50
Previous Close$74.58
Volume178.65K
Average Volume (3M)217.38K
Market Cap
$1.17B
Enterprise Value$1.71K
Total Cash (Recent Filing)$24.89M
Total Debt (Recent Filing)$385.79M
Price to Earnings (P/E)460.1
Beta1.00
Next Earnings
Nov 10, 2026EPS Estimate
0.75Next Dividend Ex-DateN/A
Dividend Yield2.34%
Share Statistics
EPS (TTM)0.17
Shares Outstanding14,922,698
10 Day Avg. Volume219,904
30 Day Avg. Volume217,381
Financial Highlights & Ratios
PEG Ratio-2.41
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$93.00Price Target Upside24.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)2.77
Revenue Forecast (FY)$846.21M
Bulls Say, Bears Say
Bulls Say
Clinic Volume And PricingSustained increases in clinic utilization and revenue per visit support organic growth and operating leverage. The 24-month streak of clinic productivity records suggests improving execution and durable patient demand.
Hospital Affiliation ExpansionHospital affiliations can broaden referral access, increase clinic utilization, and create a scalable growth channel. The remaining integrations and expected 2027 benefits provide a multi-quarter opportunity beyond the initial rollout.
Industrial Injury Prevention GrowthThe IIP segment is adding revenue without sacrificing margin, diversifying USPH beyond reimbursed clinic visits. Employer contracts and workplace musculoskeletal programs may support recurring relationships and reduce reliance on one care setting.
Bears Say
Compressed ProfitabilityThin profitability leaves limited room for reimbursement pressure, wage inflation, or execution setbacks. Lower margins and returns also reduce the company’s ability to self-fund expansion while maintaining attractive long-term earnings conversion.
Medical And Labor Cost PressureHigher benefit costs and front-loaded hiring are compressing margins even as revenue grows. Although some claims may normalize, persistent clinician and staffing expenses could limit operating leverage during the affiliation expansion.
Higher Borrowings And Softer Cash MomentumGreater debt usage and lower cash reduce financial flexibility as USPH funds acquisitions and hospital integrations. Solid cash generation is a mitigating factor, but weaker recent free-cash-flow momentum could constrain deleveraging.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $58.19 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.17B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Nov 10, 2026 which is in 78 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on Aug 05, 2026. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.814 by -$0.064.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.46 which represents an annual dividend yield of 2.34%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.75.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 14,922,698 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.75 in its last earnings report, missing expectations of $0.814. Following the earnings report the stock price went down -1.608%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$93.00 (24.70% Upside)
$93.00 (24.70% Upside)
Blogger Sentiment
Neutral
USPH Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 87.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
5.82%
12-Months-Change
Fundamentals
Return on Equity
2.34%
Trailing 12-Months
Asset Growth
5.87%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
USPH Company Deck
USPH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call portrays strong operational momentum — solid revenue growth, record visit volumes, improving revenue per visit, active M&A and an expanding hospital-affiliation pipeline that management expects will materially lift results in late 2023 and 2027. Near-term profitability was pressured by elevated employee self-insured medical costs, front-loaded hiring for hospital rollouts and integration costs, leading to margin compression, lower net income and EPS. Management reaffirmed full-year adjusted EBITDA guidance and highlighted meaningful upside from ongoing hospital affiliations and rate increases, indicating confidence in future performance.View all USPH earnings summariesUSPH Stock 12 Month Forecast
Average Price Target
$93.00
▲(24.70% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
―
Pennant Group
―
Ownership Overview
2.35% Insiders
29.63% Mutual Funds
35.42% Other Institutional Investors
5.14% Public Companies and
Individual Investors